Literature DB >> 2483932

Effect of human chorionic gonadotropin administration on pituitary and luteal response to gonadotropin-releasing hormone.

A Lanzone1, A M Fulghesu, N Di Simone, R Apa, C Guida, A Caruso, S Mancuso.   

Abstract

The effect of human chorionic gonadotropin (hCG) administration on the pituitary and luteal responses to acute gonadotropin-releasing hormone (GnRH) administration at the mid luteal phase (LP) were studied in 20 infertile women. Patients were divided into 2 groups. In 1 group (n = 8), hCG (5,000 IU i.m.) was injected in a single shot on day 5 of LP. Sixty hours later (day 8 of LP) blood samples were taken every 15 min for 180 min; then 25 micrograms GnRH were acutely administered intravenously and blood samples taken at 185, 195, 210, 225, 240, 255, 270, 285 and 300 min. In the other 12 patients the same experimental design with GnRH was performed on day 8 of an untreated LP. Plasma LH, FSH, beta-hCG, progesterone and estradiol (E2) were assayed. The responsiveness of different hormones to GnRH was evaluated as integrated secretory area for 120 min after injection (sISA) and as the absolute increase with respect to the area under basal conditions before a GnRH administration (bISA). hCG-treated patients showed higher basal and bISA plasma values of LH/hCG than controls (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483932     DOI: 10.1159/000181290

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  1 in total

1.  The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration.

Authors:  A M Fulghesu; A Lanzone; R Apa; M Guido; M Ciampelli; F Cucinelli; A Caruso; S Mancuso
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.